Cationic multilamellar liposome-mediated human interferon-β gene tranfer into cervical cancer cell

Anticancer Research

Volumn 18, Issue 3 A, 1998, Pages 1367-1371

  Tomoda, Kiyoshi ^a   Ohishi, Nobuko ^b   Kikkawa, Fumitaka ^a   Mizutani, Shigehiko ^a   Tomoda, Yutaka ^a   Yagi, Kunio ^b  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Yagi Memorial Park   (Japan)

Author keywords

Apoptosis; Cervical cancers; Gene transfer; Interferon ; Paracrine effect

Indexed keywords

BETA INTERFERON; COMPLEMENTARY DNA; LIPOSOME;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; EXPRESSION VECTOR; GENE TRANSFER; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; UTERINE CERVIX CANCER;

APOPTOSIS; AVIAN SARCOMA VIRUSES; CELL DIVISION; DNA FRAGMENTATION; DNA, COMPLEMENTARY; DRUG CARRIERS; FEMALE; GENETIC VECTORS; HELA CELLS; HUMANS; INTERFERON-BETA; LIPOSOMES; RECOMBINANT PROTEINS; TRANSFECTION; UTERINE CERVICAL NEOPLASMS;

EID: 0031857472     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Brinton LA: Epidemiology of cervical cancer - Overview. In: The epidemiology of cervical cancer and human papillomavirus (Muñoz N, Bosch FX, Shah KV and Meheus A, eds). Lyon, IARC, 1992, pp 3-23.
2. Taylor-Papadimitriou J and Balkwill RF: Implications for clinical application of new developments in interferon research. Biochim Biophys Acta 695: 49-67, 1982.
3. Quesada JR, Reuben J, Manning JT, Hersh EM and Gutterman JU: Alpha interferon for induction of remission in hairy cell leukemia. N Engl J Med 310: 15-18, 1984.
4. de Léon CG, Lippman SM, Kudelka AP, Edwards CL and Kavanagh JJ: Phase II study of cisplatin, 5-fluorouracil and interferon-α in recurrent carcinoma of the cervix. Invest New Drugs 13: 73-76, 1995.
5. Lippman SM, Glisson BS, Kavanagh JJ, Lotan R, Hong WK, Paredes-Espioza M, Hitteman WN, Holdener EE and Krakoff IH: Retinoic acid and Interferon combination studies in human cancer. Eur J Cancer 29A: S9-S13, 1993.
6. Angioli R, Seivn B-U, Perras JP, Untch M, Hightower R D, Nguyen HN, Steren A, Villani C and Averette HE: Rationale of combining radiation and interferon for the treatment of cervical cancer. Oncol 49: 445-449, 1992.
7. Welander CE, Homesley HD and Barren RJ: Combined interferon alfa and doxorubicin in the treatment of advanced cervical cancer. Am J Obstet Gynecol 165: 284-291, 1991.
8. Zhi J, Teller SB, Satoh H, Koss-Twardy SG and Luke DR: Influence of human serum albumin content in formulations on the bioequivalency of interferon alfa-2a given by subcutaneous injection in healthy male volunteers. J Clin Pharmacol 35: 281-284, 1995.
9. Ogawa M, Takaku F, Maekawa T, Ota K, Ichimaru M, Izuo M, Takakura K, Ikeda S, Koiso K, Machida T and Kato T: Phase I study of a recombinant gamma interferon (S-6810). Jpn J Cancer Chemother 14: 446-452, 1987.
10. Mizuno M, Yoshida J, Sugita K, Inoue I, Seo H, Hayashi Y, Koshizaka T and Yagi K: Growth inhibition of glioma cells transfected with the human β-interferon gene by liposome coupled with a monoclonal antibody. Cancer Res 50: 7826-7829, 1990.
11. Yagi K, Hayashi Y, Ishida N, Ohbayashi M, Ohishi N, Mizuno M and Yoshida J: Interferon-β endogenously produced by intratumoral injection of cationic liposome-encapsulated gene: Cytocidal effect on glioma transplanted into nude mouse brain. Biochem Mol Biol Int 32: 167-171, 1994.
12. Koshizaka T, Hayashi Y, Yagi K: Novel liposomes for efficient transfection of β-galactosidase gene into COS-1 cells. J Clin Biochem Nutr 7: 185-192, 1989.
13. Yagi K, Noda H, Kurono M and Ohishi N. Efficient gene transfer with less cytotoxicity by means of cationic multilamellar liposomes. Biochem Biophys Res Commun 196: 1042-1048, 1993.
14. Yagi K, Ohishi N, Ishida N, Hayashi Y, Ohbayashi M, Nishikimi M, Nagata A, Mizuno M and Yashida J: Jpn Soc Gene Therapy, Abstract p 48, 1995.
15. Sumantran VN, Ealovega MW, Nuñez G, Clarke MF and Wicha MS: Overexpression of Bcl-xs sensitizes MCF-7 cells to chemotherapy-induced apoptosis. Cancer Res 55: 2507-2510, 1995.
16. Novick D, Cohen B and Rubinstein M: The human interferon α/β receptor: Characterization and molecular clonig. Cell 77: 391-400, 1994.
17. Bangham AD, Hill MW and Miller NGA: Preparation and use of liposomes as models of biological membrane. In: Methods in membrane biology (Korn ED, ed). New York, Plenum Press, 1974, Vol. 1, pp 1-68.
18. Schroit AJ, Hart IR, Madsen J and Fidler IJ: Selective delivery of drugs encapsulated in liposomes: Natural targeting to macrophages involved in various disease states. J Biol Response Modif 2: 97-100, 1983.
19. Papahadjopoulos D: A personal view of liposomes: From membrane modeling to drug delivery. In: Medical Application of Liposomes (Yagi K ed). Tokyo, Jpn Sci Soc Press, 1986, pp 1-9.
20. 1 arrest. Nature 313: 597-600, 1985.
21. Yarden A and Kimchi A: Tumor necrosis factor reduces c-myc expression and cooperates with interferon-y in HeLa cells. Science 234: 1419-1421, 1986.
22. Nawa A, Nishiyama Y, Yamamoto N, Maeno K, Goto S and Tomoda Y: Selective suppression of human papiloma virus type 18 mRNA level in HeLa cells by interferon. Biochem Biophys Res Commun 170: 793-799, 1990.